FDA Rejects Merck Pain Pill

F.D.A. Panel Rejects Merck Pain Pill in 20-1 Vote

The F.D.A. rejected Arcoxia because of concerns that the drug could cause as many as 30,000 heart attacks a year if widely used.

Blogged with Flock